Labeled miRNA Inhibitor Neg Control

Description

Labeled RNA oligonucleotides. miRNA Inhibitor Neg Control is designed to use as a negative control in miRNA inhibitor experiments. It is a random sequence that has been tested and validated to have no effects on miRNA function.
Product Highlights

Chemically-modified and optimized nucleic acids designed to use as a negative control in miRNA inhibitor experiments.
Storage Temp

-20°C
Shipping

RT
Shelf Life

6 months
Datasheet
Notes

For research use only. Not to be used for human or animal treatment or consumption.
Additional description

Isotype or positive controls by peptides, antibodies and deactivated samples. Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme. FITC labelling for flow cytometry of antibodies and peptides.

Name

Drug Labeling
Concept

Scope note: Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
Tree numbers
- E05.916.310
Qualifiers

trends, ethics, history, classification, economics, instrumentation, methods, standards, legislation & jurisprudence, statistics & numerical data